# VIN-23 Akeso Biomedical, LLC — Form D

VIN-23 Akeso Biomedical, LLC of FAYETTEVILLE, AR, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-22. The offering totals $500K, of which $25K was reported sold. Industry: Other.

## Offering

- Filed: 2021-02-22
- Form: D
- Accession: 0001847256-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $25K
- Remaining: $475K
- Minimum investment: $5K
- Investors: 3
- Date of first sale: 2021-02-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390063

## Issuer

- Name: VIN-23 Akeso Biomedical, LLC
- CIK: 0001847256
- Entity type: Limited Liability Company
- Jurisdiction: ARKANSAS
- Incorporated: 2020
- Address: 535 W. RESEARCH CENTER BLVD., FAYETTEVILLE, AR, 72701
- Phone: 4795712592

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Robert Calvin Goforth | Director | Fayetteville, AR |
| Robert Calvin Goforth | Executive Officer | Fayetteville, AR |

## More

- [CIK 1847256 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847256&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001847256-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.